Interrupting the surgeon may endanger patients on the wardsResidents give unsafe answers when paged during surgery Few C. diff cases follow direct patient contactCurrent control measures contain but don’t eradicate the infection Leadership: A better way to build leadership Traditional methods of developing leadership effectiveness aren’t doing the job. The evidence supports a new approach Drug cuts morbidity in pulmonary arterial hypertension Editor's Note: Blurred lines Score predicts diabetes remission Trailblazers: Pushing the envelope Working with colleagues in Canada and Russia, Dr. Luis Schang has found a new way of stopping enveloped viruses from infecting cells Hospital pharmacist involvement in postsurgical patient care improves outcomes, saves money Canadian study evaluated clinical, economic outcomes after clinical pharmacist services were added to two general surgical wards. RNAO and Working for Change host community-led poverty consultation Macitentan reduces risk of mortality in PAH patients, study finds LAVAL, Que. | Actelion Pharmaceuticals Canada has announced that a pivotal study with macitentan in patients with pulmonary arterial hypertension (PAH) has demonstrated a significant reduction in morbidity and mortality. First Previous 252 253 254 255 256 Next Last
